ramipril 10mg capsules
genus pharmaceuticals ltd - ramipril - oral capsule - 10mg
nesidom 16 mg - retardtabletten
therabel pharmaceuticals ltd - molsidomin -
oxazepam 10mg tablets
genus pharmaceuticals holdings ltd - oxazepam - oral tablet - 10mg
oxazepam 15mg tablets
genus pharmaceuticals holdings ltd - oxazepam - oral tablet - 15mg
ethambutol 100mg tablets
esteve pharmaceuticals ltd - ethambutol hydrochloride - oral tablet - 100mg
ethambutol 400mg tablets
esteve pharmaceuticals ltd - ethambutol hydrochloride - oral tablet - 400mg
valsartan/hidroclorotiazida pharmagenus 160 mg/25 mg comprimidos recubiertos con pelicula efg
pharmagenus s.a. - valsartan; hidroclorotiazida - comprimido recubierto con pelÍcula - 160 mg/25 mg - valsartan 160 mg; hidroclorotiazida 25 mg - valsartán y diuréticos
modafinil- modafinil tablet
ingenus pharmaceuticals, llc - modafinil (unii: r3uk8x3u3d) (modafinil - unii:r3uk8x3u3d) - modafinil 100 mg - modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (osa), or shift work disorder (swd). limitations of use in osa, modafinil tablets are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction. if continuous positive airway pressure (cpap) is the treatment of choice for a patient, a maximal effort to treat with cpap for an adequate period of time should be made prior to initiating and during treatment with modafinil tablets for excessive sleepiness. modafinil is contraindicated in patients with known hypersensitivity to modafinil or armodafinil or its inactive ingredients [see warnings and precautions (5.1, 5.2, 5.3)] . teratogenic effects pregnancy category c there are no adequate and well-controlled studies of modafinil in pregnant women. intrauterine growth restriction and spontaneous abortion have been reported in association with modafinil (a mixture of r- and s-modaf
indomethacin capsule, extended release
ingenus pharmaceuticals, llc - indomethacin (unii: xxe1cet956) (indomethacin - unii:xxe1cet956) - indomethacin 75 mg - indomethacin extended-release capsules are indicated for: - moderate to severe rheumatoid arthritis including acute flares of chronic disease - moderate to severe ankylosing spondylitis - moderate to severe osteoarthritis - acute painful shoulder (bursitis and/or tendinitis) indomethacin extended-release capsules are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to indomethacin or any components of the drug product [see warnings and precautions ( 5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions ( 5.7, 5.8) ] - in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions ( 5.1) ] risk summary use of nsaids, including indomethacin extended-release, during the third trimester of pregnancy increases the risk of pre
fluconazole 50mg/5ml oral suspension
genus pharmaceuticals ltd - fluconazole - oral suspension - 10mg/1ml